OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2025
(5)
2022
(1)
2021
(1)
2020
(1)
2019
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Comparative Evaluation of a Multistrain Indirect ELISA Targeting Anti- p26 and gp45 Antibodies for EIAV Detection.
Not available
S-EPMC12196156
|
biostudies-literature
Cite
Sublingual ranulas, is it time for a new classification? A systematic review and meta-analysis.
Not available
S-EPMC12303724
|
biostudies-literature
Cite
Nonserologic test for COVID-19: How to manage?
Not available
S-EPMC7280620
|
biostudies-literature
Cite
Extracorporeal Septoplasty for Severe Nasal Septal Deviation: A Systematic Review.
Not available
S-EPMC12512901
|
biostudies-literature
Cite
MR Imaging in Sudden Sensorineural Hearing Loss. Time to Talk.
Not available
S-EPMC7960407
|
biostudies-literature
Cite
Anti-IL5/IL-5 receptor therapies for eosinophilic granulomatosis with polyangiitis: an updated Systematic Review.
Not available
S-EPMC12321870
|
biostudies-literature
Cite
Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis.
Not available
S-EPMC6603022
|
biostudies-literature
Cite
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.
Not available
S-EPMC12209767
|
biostudies-literature
Cite
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy.
Not available
S-EPMC7648897
|
biostudies-literature
Cite
Novel Multidisciplinary Salivary Gland Society (MSGS) Questionnaire: An International Consensus.
Not available
S-EPMC9291943
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets